Tags : Forendo Pharma

Novartis Signs Worldwide License Agreement with Forendo Pharma to Discover

Shots: Forendo to receive up front, equity investment, development, regulatory and commercial milestones with royalties on sales. Novartis to fund the research activities and will be responsible for development, manufacturing & commercialization of novel therapies Forendo has its expertise in an enzyme family called HSD17B (17-beta-hydroxysteroid dehydrogenase) responsible for regulating hormone action with its lead […]Read More